About EnzymeNews

EnzymeNews covers enzyme research and its applications in biotechnology, health, industry and the environment. It aims to help students, researchers and scientifically curious readers understand what studies found, their limitations, and what further work may be needed before findings can be applied in practice.

Owner and editor

EnzymeNews is owned and edited by Dr. Matheus Regis Belisário Ferrari, a scientist based in Germany. He holds a PhD and has a research background in biotechnology, biochemistry, molecular biology and enzyme engineering.

Research sources and AI assistance

AI tools assist with article drafting. Before publication, Dr. Ferrari checks articles against their original research sources and takes responsibility for the published content.

The editorial aim is to distinguish research findings from interpretation, explain important limitations, and identify the stage of research—for example, laboratory experiments, animal studies or human trials. Readers can consult the research sources cited in each article.

Corrections and updates

Readers are welcome to report factual errors or suggest clarifications through the Contact Us page. Please include the article’s address, the passage concerned and a supporting source where available.

Substantial corrections are recorded with a dated note explaining what changed.

Health information

Health-related articles provide general scientific information and do not replace advice from a qualified healthcare professional.